Hospira, which expects to launch the product by the end of February, said topotecan 4 mg/4 ml is designed to improve caregiver convenience and safety.
Hospira US president Thomas Moore said their solution version of topotecan expands their portfolio of value-added generics.
Hospira, a global specialty pharmaceutical and medication delivery company, offers generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions.